During the past decade, Watson Clinic Center for Cancer Care and Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 17 clinical trials were completed, i.e. on average, 566.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Watson Clinic Center for Cancer Care and Research" #1 sponsor was "SCRI Development Innovations, LLC" with 19 trials, followed by "H. Lee Moffitt Cancer Center and Research Institute" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "CTI BioPharma" with 2 trials sponsored and "NSABP Foundation Inc" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Watson Clinic Center for Cancer Care and Research" #1 collaborator was "Genentech, Inc." with 7 trials as a collaborator, "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Celgene Corporation" with 4 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Watson Clinic Center for Cancer Care and Research" are "Breast Cancer" (9 trials), "Carcinoma, Small Cell" (2 trials), "Esophageal Cancer" (2 trials), "Lung Cancer" (2 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Watson Clinic Center for Cancer Care and Research" in a lesser frequency.

Most popular intervention types in "Watson Clinic Center for Cancer Care and Research" are "Drug" (32 trials), "Other" (4 trials), "Radiation" (4 trials), "Procedure" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (7 trials), "Carboplatin" (6 trials), "Gemcitabine" (5 trials), "Cyclophosphamide" (3 trials) and "Lenalidomide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Watson Clinic Center for Cancer Care and Research" are 27 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Watson Clinic Center for Cancer Care and Research". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Watson Clinic Center for Cancer Care and Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Watson Clinic Center for Cancer Care and Research, 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".